Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 931Neoplasms 705Prostatic Neoplasms 487Lung Neoplasms 390Colorectal Neoplasms 359Carcinoma, Non-Small-Cell Lung 356Leukemia, Myeloid, Acute 278Pancreatic Neoplasms 233Brain Neoplasms 223Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 180Glioblastoma 180Melanoma 173Ovarian Neoplasms 167Squamous Cell Carcinoma of Head and Neck 158Recurrence 143Rectal Neoplasms 142Uterine Cervical Neoplasms 140Sarcoma 134Hematologic Neoplasms 131Glioma 128Stomach Neoplasms 127Triple Negative Breast Neoplasms 126Carcinoma, Renal Cell 123Esophageal Neoplasms 109Colonic Neoplasms 109Myelodysplastic Syndromes 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dihydropyrimidine Dehydrogenase Deficiency × 90 days × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡